Choriocarcinoma (Gestational Trophoblastic Neoplasia) drugs in development, 2023

GlobalData tracks 5 drugs in development for Choriocarcinoma (Gestational Trophoblastic Neoplasia) by four companies/universities/institutes. The top development phase for Choriocarcinoma (Gestational Trophoblastic Neoplasia) is phase i, with four drugs in that stage.

FDA announces recall of heart pumps linked to deaths and injuries

A pair of heart devices linked to hundreds of injuries and at least 14 deaths has received the FDA’s most serious recall, the agency announced

April 16, 2024

FDA Warns Amazon Over Supplements Containing Erectile Dysfunction Drugs

The FDA hit Amazon with a warning letter on December 20 for distributing energy supplements for men that contain potentially harmful pharmaceutical ingredients. These products,

December 30, 2023

A Twice-Yearly Shot Could Help End AIDS. But Will It Get to Everyone Who Needs It?

It’s been called the closest the world has ever come to a vaccine against HIV. The twice-yearly shot was 100% effective in preventing HIV infections

December 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.